YT
Therapeutic Areas
Nipro Corporation Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Dialyzers & Renal Care Portfolio | End-stage renal disease (Hemodialysis) | Commercial |
| Infusion Therapy Systems | Fluid & drug delivery | Commercial |
| Blood Glucose Monitoring (Glutest) | Diabetes management | Commercial |
| Syringes & Needles | Vaccination & drug injection | Commercial |
| Generic Injectable Pharmaceuticals | Various (e.g., antibiotics) | Approved & Development |
| Pharmaceutical Packaging | Drug containment & delivery | Commercial |
| Contrast Media | Diagnostic imaging | Commercial |
| Surgical & Interventional Devices | Surgical procedures | Commercial |
Leadership Team at Nipro Corporation
YS
Yoshihiko Sano
Representative Director, President & Chief Executive Officer
MO
Mitsuo Ohashi
Representative Director, Senior Managing Executive Officer
HN
Hiroshi Noguchi
Director, Senior Managing Executive Officer
YS
Yoshikazu Saito
Director, Managing Executive Officer
TO
Tetsuo Otsubo
Director, Managing Executive Officer
KK
Kazuhiko Kikkawa
Director, Managing Executive Officer
YT
Yoshihiko Tamura
Director, Managing Executive Officer
MK
Masahiko Kuwahara
Director, Managing Executive Officer
YI
Yoshinori Ishigaki
Director, Managing Executive Officer
YI
Yoshihiro Ikuta
Director, Managing Executive Officer